Takeda gets China’s approval for $62 billion Shire purchase

Japan’s Takeda Pharmaceutical Co Ltd said on Friday China’s market regulator had approved its $62 billion acquisition of Shire Plc , bringing it closer to becoming a global top 10 drugmaker.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News